Evaluating the effects of cannabis use in cancer patients receiving treatment
Official title: Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics
Funded at Wake Forest University Health Sciences · NIH-10932967 · Data updated 2026-11-12
This study is looking at how cannabis and its compounds can help cancer patients feel better during their treatment, focusing on both the good and any possible downsides, so we can learn more about how it affects their symptoms and overall experience.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project start | September 21, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $619,471 |
| NIH project number | 5U01CA286813-02 |
| Project ID | NIH-10932967 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are cancer patients aged 21 and older who are currently undergoing treatment and considering or using cannabis for symptom relief.
✕Less likely to help
Patients who are not currently undergoing cancer treatment or those who do not use cannabis may not benefit from this research.
What this research studies
This research investigates how cannabis and cannabinoids affect cancer patients who are undergoing treatment in community oncology clinics. It aims to assess both the benefits and potential harms of cannabis use, particularly focusing on symptom relief for physical and neuropsychiatric issues that are often inadequately managed by conventional medications. By analyzing patient experiences and outcomes, the study seeks to provide clearer evidence on the efficacy and safety of cannabis products, which vary widely in composition and effects. The research will involve collecting data from a cohort of cancer patients to better understand their usage patterns and the impact on their treatment.
Why it matters
Potential benefit: If successful, this research could provide valuable insights into the safe and effective use of cannabis for symptom management in cancer patients.
How similar studies have gone: While there is ongoing debate about the efficacy of cannabis in medical settings, this research aims to fill gaps in existing literature, suggesting that it may provide new insights rather than simply replicating previous findings.
Where this research is happening
-
Wake Forest University Health Sciences
Winston-Salem, United States Active
Researchers
- Principal investigator: Reboussin, Beth a. — Wake Forest University Health Sciences
- Study coordinator: Reboussin, Beth a.
Related research
Other NIH-funded projects on the same topics.
-
Hemp-derived CBD for reducing cannabis use in high-THC concentrate users
A randomized, placebo-controlled trial tests whether hemp-derived CBD can help adults who mainly use high-potency cannabis concentrates reduce their cannabis use.
-
Understanding how minority stress affects cannabis use in sexual minorities
A research project follows young adult sexual minorities to see how daily stress and coping help explain cannabis use and related problems.
-
Repeated cannabis with different THC/CBD mixes and how it affects pain, cravings, and body chemicals
This project studies how taking cannabis repeatedly, with different THC and CBD amounts, changes pain experiences, potential for abuse, and levels of body chemicals related to the endocannabinoid system in adults.
-
Terminal cannabinoid CB1 receptor changes in schizophrenia and cannabis use
This grant studies how cannabis use and schizophrenia together affect a brain receptor (CB1) and what that could mean for memory and symptoms.
-
Cannabis policies and prenatal cannabis use: how laws affect moms and babies
This grant studies how changes in recreational cannabis laws influence cannabis use during pregnancy and health outcomes for mothers and children.
-
Youth and social media marketing of hemp-derived cannabis products
Young people are increasingly exposed to hemp-derived cannabis product marketing on social media, and this study looks at how that marketing might influence their attitudes and curiosity.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.